Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT06356129
Title Study to Compare the Effectiveness and Safety of Golcadomide Plus R-CHOP vs Placebo Plus R-CHOP in Participants With Previously Untreated High-risk Large B-cell Lymphoma (GOLSEEK-1)
Acronym GOLSEEK-1
Recruitment Not yet recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Celgene
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | NZL | FRA | ESP | DEU | CAN | AUT | AUS


No variant requirements are available.